130 related articles for article (PubMed ID: 34282106)
1. PTEN Loss and ARID1A Mutation in an HPV-positive Metastatic Adenocarcinoma Diagnosed Almost 18 yr After an Intact Cone Excision for Endocervical Adenocarcinoma In Situ.
Aisagbonhi O; Zare SY; Hasteh F; Binder P; Roma AA; Fadare O
Int J Gynecol Pathol; 2022 May; 41(3):307-312. PubMed ID: 34282106
[TBL] [Abstract][Full Text] [Related]
2. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
3. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
[TBL] [Abstract][Full Text] [Related]
4. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
5. HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
Arfi A; Hequet D; Bataillon G; Tran-Perennou C; Farkhondeh F; Sastre-Garau X; Fourchotte V; Rouzier R; Laas E; Pouget N; Vincent-Salomon A; Jeannot E
BMC Cancer; 2019 Apr; 19(1):375. PubMed ID: 31014281
[TBL] [Abstract][Full Text] [Related]
6. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
[TBL] [Abstract][Full Text] [Related]
7. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus-Related Ovarian Metastasis With Endocervical Adenocarcinoma: Report of 2 Cases and Review of Literature.
Turashvili G; Farmer P; Colgan T; Childs T
J Low Genit Tract Dis; 2015 Oct; 19(4):e60-3. PubMed ID: 26360235
[TBL] [Abstract][Full Text] [Related]
9. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM
Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
[TBL] [Abstract][Full Text] [Related]
10. Endocervical adenocarcinoma in situ (AIS) with ovarian and pulmonary involvement: report of a case and review of the literature suggesting a "seed and soil hypothesis".
Horn LC; Höhn AK; Stark S; Einenkel J; Borte G; Haak A; Siebolts U; Brambs CE
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2061-2069. PubMed ID: 31309301
[TBL] [Abstract][Full Text] [Related]
11. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
[TBL] [Abstract][Full Text] [Related]
12. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
13. Endocervical adenocarcinoma in situ presenting in fundal endometrial polyp: the mother of all skip lesions.
Roberts JM; Cornall AM; Lamaro V; Tabrizi SN; Russell P
Int J Gynecol Pathol; 2015 May; 34(3):228-31. PubMed ID: 25844546
[TBL] [Abstract][Full Text] [Related]
14. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
15. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
Huang SS; Sui L; Chen LM; Zhang HW; Tao X
Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
[No Abstract] [Full Text] [Related]
16. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.
Minaguchi T; Yoshikawa H; Nakagawa S; Yasugi T; Yano T; Iwase H; Mizutani K; Shiromizu K; Ohmi K; Watanabe Y; Noda K; Nishiu M; Nakamura Y; Taketani Y
Cancer Lett; 2004 Jul; 210(1):57-62. PubMed ID: 15172121
[TBL] [Abstract][Full Text] [Related]
17. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
18. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
[TBL] [Abstract][Full Text] [Related]
19. Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.
Cohen PA; Brand A; Sykes P; Wrede DCH; McNally O; Eva L; Rao A; Campion M; Stockler M; Powell A; Codde J; Bulsara MK; Anderson L; Leung Y; Farrell L; Stoyles P
BMJ Open; 2017 Aug; 7(8):e017576. PubMed ID: 28851799
[TBL] [Abstract][Full Text] [Related]
20. Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
Sánchez-Cuerda C; Cuadra M; Gámir S; Lobo P; Elices M; Cabrera Y
Int J Gynaecol Obstet; 2022 Jul; 158(1):21-26. PubMed ID: 34559882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
